SG Americas Securities LLC reduced its position in shares of Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 13.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 799,245 shares of the real estate investment trust's stock after selling 124,511 shares during the period. SG Americas Securities LLC owned about 0.13% of Medical Properties Trust worth $4,819,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Indie Asset Partners LLC raised its position in shares of Medical Properties Trust by 16.7% during the 4th quarter. Indie Asset Partners LLC now owns 15,384 shares of the real estate investment trust's stock valued at $61,000 after acquiring an additional 2,204 shares in the last quarter. Sei Investments Co. raised its position in shares of Medical Properties Trust by 6.6% during the 4th quarter. Sei Investments Co. now owns 39,252 shares of the real estate investment trust's stock valued at $155,000 after acquiring an additional 2,438 shares in the last quarter. Farther Finance Advisors LLC raised its position in shares of Medical Properties Trust by 49.5% during the 1st quarter. Farther Finance Advisors LLC now owns 7,875 shares of the real estate investment trust's stock valued at $47,000 after acquiring an additional 2,606 shares in the last quarter. Nissay Asset Management Corp Japan ADV raised its position in shares of Medical Properties Trust by 5.6% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 49,953 shares of the real estate investment trust's stock valued at $186,000 after acquiring an additional 2,661 shares in the last quarter. Finally, Atria Wealth Solutions Inc. raised its position in shares of Medical Properties Trust by 2.7% during the 4th quarter. Atria Wealth Solutions Inc. now owns 111,490 shares of the real estate investment trust's stock valued at $440,000 after acquiring an additional 2,948 shares in the last quarter. 71.79% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on MPW. Wells Fargo & Company upped their price target on Medical Properties Trust from $4.00 to $5.00 and gave the company an "underweight" rating in a research report on Monday, March 10th. BNP Paribas raised Medical Properties Trust from a "neutral" rating to an "outperform" rating and upped their price target for the company from $5.00 to $9.00 in a research report on Wednesday, March 12th. Wall Street Zen raised Medical Properties Trust from a "sell" rating to a "hold" rating in a research report on Monday, March 3rd. Finally, Royal Bank of Canada increased their target price on Medical Properties Trust from $4.00 to $5.00 and gave the stock a "sector perform" rating in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, Medical Properties Trust currently has an average rating of "Hold" and a consensus price target of $5.75.
View Our Latest Analysis on Medical Properties Trust
Medical Properties Trust Stock Performance
NYSE MPW traded down $0.09 during trading hours on Friday, hitting $4.41. The company had a trading volume of 6,085,530 shares, compared to its average volume of 11,789,028. Medical Properties Trust, Inc. has a fifty-two week low of $3.51 and a fifty-two week high of $6.55. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 1.69. The business has a fifty day simple moving average of $4.99 and a 200-day simple moving average of $4.85. The firm has a market cap of $2.65 billion, a P/E ratio of -1.04, a price-to-earnings-growth ratio of 1.01 and a beta of 1.32.
Medical Properties Trust (NYSE:MPW - Get Free Report) last issued its earnings results on Thursday, May 1st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The business had revenue of $223.80 million during the quarter, compared to analysts' expectations of $233.80 million. During the same quarter in the previous year, the company earned $0.24 earnings per share. Medical Properties Trust's revenue for the quarter was down 17.5% compared to the same quarter last year. Equities analysts predict that Medical Properties Trust, Inc. will post 0.78 EPS for the current year.
Medical Properties Trust Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 17th. Stockholders of record on Wednesday, June 18th will be paid a $0.08 dividend. The ex-dividend date is Wednesday, June 18th. This represents a $0.32 annualized dividend and a dividend yield of 7.26%. Medical Properties Trust's payout ratio is -11.55%.
About Medical Properties Trust
(
Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also

Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.